title: Reply letter to: pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participant - reply to Füssenich et al.: a new, simple and objective prognostic score for phase I cancer patients.
authors.forename: C M L
authors.initials: CM
authors.lastname: van Herpen
authors.forename: S
authors.initials: S
authors.lastname: Teerenstra
authors.forename: I M E
authors.initials: IM
authors.lastname: Desar
authors.forename: W T A
authors.initials: WT
authors.lastname: van der Graaf
mesh_terms: D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000592:standards*